Sentence examples for iv device from inspiring English sources

A Nicolet Viking IV device (Nicolet® Biomedical, Madison, Wisconsin, USA) was used for stimulation single fiber electromyography [12].

7 This means that home testing must be performed with a type III device, now usually using 4 7 channels, rather than a type IV device, as represented by an oximeter, recording only pulse rate and oxygen saturation.

The relevant data items for an MDR are: (i) device type and model, (ii) report source (e.g. hospital or manufacturer), (iii) event date and location, (iv) device age, (v) patient outcome, (vi) a narrative of the event, and (vii) the manufacturers evaluation of returned devices if available.

Many type IV devices include other channels, such as pulse rate, but their scoring of respiratory events is based mainly on the ODI.

The level and amount of evidence required for licensing a specific new device (or group of devices) depends on the classification of risk assigned to that device: the greatest degree of rigour is required for evidence of safety and efficacy in Class IV devices.

For new Class II to Class IV devices, licenses may be approved without evidence of safety or effectiveness, if the new device is "substantially equivalent" to a licensed device, or is a "family member" of an already licensed product [ 7, 10].

The PMDA address two conflicting goals: the first is to assure the public that the devices are reasonably safe and effective; and the second is to avoid overregulation of manufacturers in the development of Class III or IV devices (Post-marketing measures for drug/medical devices).

Oxygen isotopic measurements were taken with an MAT 253 mass spectrometer with a Kiel IV carbonate device installed at the Department of Geology and Paleontology, National Museum of Nature and Science.

The architecture is hosted in a medium-scale Cyclone IV FPGA device clocked at 21.7 MHz and is capable of extracting a feature with its descriptor at every clock cycle, i.e. in 46 ns.

The advances in the development of OPVs can be attributed to four fronts: (i) a better understanding of the mechanism of photon-to-electron conversion; (ii) new materials with tailored energy levels and solubility; (iii) new processing approaches to induce optimal microstructures in the active layer; and (iv) new device architectures with novel interfacial layers.

Fluid administration using intravenous (IV) access devices is required in many settings.